Smofkabiven 0.22 g

SMOFKABIVEN 0.22 G is an intravenous emulsion containing methionine, an essential amino acid. It is used to support nutritional needs in clinical settings. This product is manufactured by Fresenius Kabi Canada Ltd.

SMOFKABIVEN 0.22 G is primarily used to provide essential amino acids, including methionine, to patients who cannot obtain adequate nutrition through oral intake. It is often administered intravenously to support metabolic processes and overall health. This emulsion is commonly used in clinical settings to address nutritional deficiencies and support recovery.

When administered intravenously, SMOFKABIVEN 0.22 G provides essential amino acids that the body needs for various metabolic functions. Patients may experience improved nutritional status and support for overall health. However, individual responses can vary, and it is important to follow medical guidance.

SMOFKABIVEN 0.22 G should be handled with care and administered under medical supervision. It is important to check for any signs of contamination or damage before use. Patients with known allergies to any of the components should avoid this product. Always follow the instructions provided by healthcare professionals.

SMOFKABIVEN 0.22 G may interact with other medications or supplements. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain CYP inhibitors may also affect the efficacy and safety of this product.